Where does Verily Life Sciences LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Verily Life Sciences LLC ranks #478 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Verily Life Sciences LLC hold?

Verily Life Sciences LLC holds 926 US utility patents granted between 2016 and 2025, spanning 141 technology areas.

What is Verily Life Sciences LLC's Innovation Score?

Verily Life Sciences LLC has an Innovation Score of 64.6 out of 100 (top 2% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Verily Life Sciences LLC focus on?

Verily Life Sciences LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 474 patents. Grants appear in 141 CPC subclasses total.

Is Verily Life Sciences LLC's patent grant rate increasing or decreasing?

Verily Life Sciences LLC's recent grant velocity is +39% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Verily Life Sciences LLC's patents?

Verily Life Sciences LLC's patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Verily Life Sciences LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Verily Life Sciences LLC

USPTO PatentsView assignee record - 926 granted patents across 141 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Verily ranks #478 of 49,997 tracked US assignees by granted-patent volume, with 926 patents across 141 technology areas.

#478
of 49,997 US assignees by volume: Top 2%
by Innovation Score (64.6/100): 18.8
avg claims per patent: +39%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R478 · US Corporation #478 · 926 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 926 grants
TOP-DECILE #478/49,997
PHOTO-FINISH Zeon
CPC-WIDE A61B · 141 areas
INNOV-STRONG 64.6/100
CLAIMS-RICH 18.8 claims/avg
TYPE-USCORP US Corporation
VEL-UP +39% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Zeon Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Verily Life Sciences · this assignee

65
HRL Laboratories · near

65
Olympus · near

65
San Diego State… · near

65
Trinamix · near

65
3D Lighting… · lowest

7

What this shows Verily's Innovation Score is 64.6/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Verily's grant cadence moved

Between 2020–2024, Verily Life Sciences LLC received 498 grants versus 358 in 2015–2019 (+39% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2020 at 131 grants and bottomed in 2016 at 36. Lead class A61B accounts for 51.2% of the portfolio across 141 subclasses. Volume neighbours: Wacom Co., Ltd. (#474) and THE University OF Tokyo (#482).

Verily's three-year grant acceleration

From 2019–2021 to 2022–2024, Verily Life Sciences LLC moved from 367 to 258 grants (0.70x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,144. See the growth leaderboard.

Wacom

933
Lumileds

930
IHI

928
Level 3 Communica…

928
Zeon

926
Verily Life Scien… ◀

926
Eaton

924
Baidu USA

922
THE University OF…

920

What this shows Verily holds 926 patents at rank #478, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Verily

By rank, the assignees closest to #478 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Verily's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Verily, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (65 here).

HRL Laboratories, LLC 65 Olympus Corporation 65 Trinamix GMBH 65 San Diego State University (SDSU) Foundation 65

Similar claim depth

Nearest assignees by average claims per patent (18.8 here).

Commscope Technologies LLC 18.8 avg Hill-Rom Services, Inc. 18.8 avg Halliburton Energy Services, Inc. 18.8 avg NIO USA, Inc. 18.8 avg

Verily's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

65 Top 2% higher than 98% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Verily Life Sciences LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	36	3.9%
2017	85	9.2%
2018	110	11.9%
2019	127	13.7%
2020	131	14.1%
2021	109	11.8%
2022	89	9.6%
2023	87	9.4%
2024	82	8.9%
2025partial year	70	7.6%

Which technologies does Verily Life Sciences LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 474

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 152

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 147

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 95

G06F - Electric Digital Data Processing 93

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 85

G06T - Image Data Processing OR Generation, IN General 82

G02B - Optical Elements, Systems OR Apparatus 69

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 63

G06N - Computing Arrangements Based ON Specific Computational Models 54

G06V - Image OR Video Recognition OR Understanding 51

H04N - Pictorial Communication, e.g. Television 48

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 43

H04B - Transmission 40

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 38

Top 15 of 141 technology areas

Where it ranks

Overall rank by patents

#478

of 49,997 tracked assignees

Innovation Score

64.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Verily Life Sciences LLC's patent record in context - here's where to go next.

Verily Life Sciences LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 51.2% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #478 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Verily Life Sciences LLC against Wacom Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 64.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.